FY17
Assets12.93
Net Worth3.88
Total Debt4.84
RevenueAnnualised basis24.53
EBITDAAnnualised basis24.24
PATAnnualised basis0.64
EBITDA Margin (%)98.82
At a glance
Updated 2026-09-08Indo US Bio-Tech is an IPO with an issue size of ₹7.29 crore, proposed for listing on NSE EMERGE.
Issue details
Listing atNSE EMERGE
Issue size₹7.29 Cr
Price band—–—
Grey market
GMP page ↗Latest GMPNO GMP
GMP / upper priceNO DATA
Est. listingNO DATA
GMP is unofficial sentiment data, not an exchange price.
Subscription demand
Full bidding ↗NO DATAWaiting for a verified live exchange update.
Company
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Assets20.55₹ Cr · +167.9% vs prior year
Net Worth4.62₹ Cr · +59.9% vs prior year
FY16
Assets13.68
Net Worth3.24
Total Debt4.66
RevenueAnnualised basis19.04
EBITDAAnnualised basis19.25
PATAnnualised basis0.35
EBITDA Margin (%)101.10
FY15
Assets7.67
Net Worth2.89
Total Debt1.66
RevenueAnnualised basis19.57
EBITDAAnnualised basis19.83
PATAnnualised basis0.49
EBITDA Margin (%)101.33
31-Oct-17
Assets20.55
Net Worth4.62
Total Debt6.37
RevenueAnnualised basis15.84
EBITDAAnnualised basis15.40
PATAnnualised basis0.74
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Indo US Bio-Tech IPO | — | 19.00 x | — | — |
| Pajson Agro IPO | — | 9.90 x | — | — |
| Shri Ahimsa IPO | — | 14.25 x | — | — |
| Swasth Foodtech IPO | — | 15.05 x | — | — |
Registrar & lead managers
Lead managers
- Location
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-08.
IPO UPDATE ALERTS
Register for IPO Updates →Track Indo US Bio-Tech without missing an update
Register for subscription, GMP, allotment and listing notifications.